It could be wasting money of marginal players, or it could also be that, incredibly, players have been increasingly underpaid versus rising revenues for several years and the pay is just now beginning to catch up.
If the latter is true, then the $64 question will be, will Baby Doc respond competitively when it’s time again to do so, or will he fight against a shifted market and repeatedly get outbid for players we can actually use to help put us over the top? That’s a question we probably won’t know the answer to until at least next offseason, and perhaps not for two.